浏览全部资源
扫码关注微信
江西中医药大学 中医学院,南昌 330004
[第一作者] 刘超,在读硕士,从事方剂作用机制及药效物质基础研究,E-mail:214982794@qq.com
*姚凤云,博士,教授,从事方剂配伍规律与现代研究,Tel:0791-87118923,E-mail:hrbyaoyao2000@163.com
收稿日期:2019-04-17,
网络出版日期:2019-08-02,
纸质出版日期:2020-01-05
移动端阅览
刘超, 左铮云, 王炳志, 等. 加味温胆汤对雌性营养性肥胖大鼠LEP,ACC和MCA的影响[J]. 中国实验方剂学杂志, 2020,26(1):87-91.
Chao LIU, Zheng-yun ZUO, Bing-zhi WANG, et al. Effect of Modified Wendantang on LEP, ACC and MCA in Female Nutritional Obese Rats[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(1): 87-91.
刘超, 左铮云, 王炳志, 等. 加味温胆汤对雌性营养性肥胖大鼠LEP,ACC和MCA的影响[J]. 中国实验方剂学杂志, 2020,26(1):87-91. DOI: 10.13422/j.cnki.syfjx.20192202.
Chao LIU, Zheng-yun ZUO, Bing-zhi WANG, et al. Effect of Modified Wendantang on LEP, ACC and MCA in Female Nutritional Obese Rats[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(1): 87-91. DOI: 10.13422/j.cnki.syfjx.20192202.
目的:
2
通过检测大鼠组织中瘦素(LEP),乙酰辅酶A羧化酶(ACC)和丙二酸单酰辅酶A(MCA)相关蛋白及其基因的表达水平,探讨加味温胆汤有效改善雌性营养性肥胖大鼠脂质代谢紊乱的作用机制和量效关系。
方法:
2
将50只SD雌性大鼠按体质量随机分为5组,分别为正常组,模型组,加味温胆汤高、中、低剂量组(18.2,9.1,4.55 g·kg
-1
)。除正常组外,其余均采用“普通饲料+高脂乳剂+碳酸饮料”混合饲养法建立营养性肥胖大鼠模型,连续灌胃给药5周,各组动物经末次给药后,麻醉取材。采用酶联免疫吸附测定(ELISA)分别检测各组大鼠血清LEP,肝和腓肠肌组织ACC的含量。采用实时荧光定量聚合酶链式反应(Real-time PCR)检测各组大鼠下丘脑组织LEP,MCA mRNA和肝组织ACC2 mRNA的表达水平。
结果:
2
与正常组比较,模型组大鼠体质量、脂肪指数显著增加(
P
<
0.05);与模型组比较,加味温胆汤中剂量组可显著下调下丘脑组织LEP,MCA mRNA的表达水平(
P
<
0.01),加味温胆汤低剂量组显著下调大鼠血清LEP,下丘脑组织LEP,MCA mRNA和肝组织ACC2 mRNA的表达水平(
P
<
0.05,
P
<
0.01);与加味温胆汤高剂量组比较,中剂量组在下调下丘脑LEP,MCA mRNA的表达水平效果最佳,低剂量组次之(
P
<
0.05,
P
<
0.01)。
结论:
2
加味温胆汤抗雌性大鼠营养性肥胖的作用机制与干预大鼠LEP抵抗,降低肝组织ACC2 mRNA和下丘脑MCA mRNA的表达水平有关,其中以中、低剂量组效果更佳。
Objective:
2
To detect the expression levels of leptin (LEP)
acety-coenzyme A carboxylase(ACC) and malonyl-CoA (MCA)-related proteins and their genes in rat tissues
in order to explore the mechanism and dose-effect relationship of modified Wendantang in alleviating lipid metabolism disorder in female nutritional obese rats.
Method:
2
Totally 50 SD female rats were randomly divided into 5 groups according to body weight
namely the normal control group
the model control group
and high
medium and low-dose modified Wendantang groups (18.2
9.1
4.55 g·kg
-1
). Except the normal control group
the remaining rats were fed with " common feed + high fat emulsion + carbonated beverage" to establish the model of nutritional obesity
and then continuously given drugs by gavage for 5 weeks. After the last drug administration to animals in each group
the rats were anaesthetized to collect materials. The serum LEP
and liver and gastrocnemius ACC levels in each group were detected by enzyme-linked immunosorbent assay (ELISA). Quantitative real-time fluorescence polymerase chain reaction (Real-time PCR) was used to detect the expressions of LEP
MCA and ACC2 mRNA in the hypothalamus and liver tissues of each group.
Result:
2
Compared with the normal control group
the body weight and fat index of the model control group increased significantly (
P
<
0.05). Compared with the model control group
the medium-dose modified Wendantang group could significantly down-regulate the expressions of LEP
MCA mRNA in rat hypothalamus (
P
<
0.01). The low-dose group can significantly down-regulate the expression levels of serum LEP
hypothalamus tissue LEP
MCA mRNA and liver tissue ACC2 mRNA (
P
<
0.05
P
<
0.01). Compared with the high-dose modified Wendantang group and the middle-dose modified Wendantang group had the best effect in down-regulating the expressions of LEP and MCA mRNA in the hypothalamus of rats
which were followed by the low-dose group (
P
<
0.05
P
<
0.01).
Conclusion:
2
The mechanism of modified Wendantang against nutritional obesity in female rats is related to the intervention of LEP resistance and the decrease of the expression level of ACC2 mRNA in liver tissue and MCA mRNA in hypothalamus tissue. The middle and low-dose groups have a better effect.
D Abdulhussein , E Amin . Translation of the link between cancer and obesity to patients [J]. Lancet , 2018 , 391 ( 10116 ): 121 - 122 .
曹佳莉 , 卢新政 . 2013美国心脏协会/美国心脏病学院/美国肥胖学会关于成人超重与肥胖管理指南解读 [J]. 中华高血压杂志 , 2014 , 22 ( 9 ): 813 - 816 .
T Pischon , H Boeing , K Hoffmann , et al . General and abdominal adiposity and risk of death in Europe [J]. N Engl J Med , 2008 , 359 ( 20 ): 2105 - 2120 .
姚凤云 , 王雅乐 , 刘成 , 等 . 加味温胆汤不同配伍药组对大鼠营养性肥胖的影响 [J]. 中国实验方剂学杂志 , 2015 , 21 ( 21 ): 134 - 138 .
姚凤云 , 刘春花 , 刘成 , 等 . 加味温胆汤抗大鼠营养性肥胖的机制探讨 [J]. 中国实验方剂学杂志 , 2013 , 19 ( 19 ): 280 - 282 .
陈玄晶 , 陈小光 , 徐丹苹 , 等 . 温胆汤调节血脂异常系统评价 [J]. 中国中医药信息杂志 , 2017 , 24 ( 8 ): 93 - 98 .
兰希仁 . 黄连温胆汤加减对老年代谢综合征胰岛素抵抗及血清瘦素的影响 [J]. 中国实验方剂学杂志 , 2012 , 18 ( 21 ): 313 - 315 .
黄慧芹 . 加味温胆汤治疗单纯性肥胖症52例临床观察 [J]. 中医临床研究 , 2010 , 2 ( 16 ): 58 - 59 .
俞若熙 , 李英帅 , 王琦 . 中医干预肥胖人群的3个问题 [J]. 中华中医药杂志 , 2016 , 31 ( 10 ): 3901 - 3903 .
姚海强 , 李玲孺 , 张曾亮 , 等 . 基于中医痰湿体质探讨代谢紊乱相关疾病危险人群的健康管理 [J]. 中华中医药学刊 , 2015 , 33 ( 6 ): 1327 - 1330 .
孙璐 , 唐咸玉 , 张鹏 , 等 . 益气化痰活血法改善超重/肥胖2型糖尿病患者糖脂代谢紊乱及肥胖抑制素的临床观察 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 6 ): 180 - 185 .
姚凤云 , 彭仁才 , 刘成 , 等 . 加味温胆汤及其拆方配伍抗大鼠营养性肥胖的药效学研究 [J]. 时珍国医国药 , 2012 , 23 ( 8 ): 1923 - 1924 .
Y Y ZHANG , R Proenca , M Maffei , et al . Positional cloning of the mouse obese gene and its human homologue [J]. Nature , 1994 , 372 ( 6505 ): 425 - 432 .
K Bouyer , R B Simerly . Neonatal leptin exposure specifies innervation of presympathetic hypothalamic neurons and improves the metabolic status of leptin-deficient mice [J]. J Neursci , 2013 , 33 ( 2 ): 840 - 851 .
R L Leshan , M Greenwald-Yarnell , C M Patterson , et al . Leptin action through hypothalamic nitric oxide synthase-1-expressing neurons controls energy balance [J]. Nat Med , 2012 , 18 ( 5 ): 820 - 823 .
R V Considine , M K Sinha , M L Heiman , et al . Serum immunoreactive-leptin concentrations in normal-weight and obese humans [J]. N Engl J Med , 1996 , 334 ( 5 ): 292 - 295 .
P J Enriori , A E Evans , P Sinnayah , et al . Leptin resistance and obesity [J]. Obesity , 2006 , 14 ( 5 ): 254S - 258S .
苏卫 , 马晓红 , 张文明 , 等 . 肥胖大鼠瘦素信号传导通路的变化 [J]. 中国比较医学杂志 , 2010 , 20 ( 5 ): 15 - 20,84 .
杨晓宁 , 张辰雨 , 王炳蔚 , 等 . 瘦素信号与瘦素抵抗机制研究进展 [J]. 生理科学进展 , 2015 , 46 ( 5 ): 327 - 333 .
M J Wolfgang , M D Lane . Hypothalamic malonyl-coenzyme A and the control of energy balance [J]. Mol Endocrinol , 2008 , 22 ( 9 ): 2012 - 2020 .
R Lag , C Dieguez , A VidalPuig , et al . AMPK:a metabolic gauge regulating whole body energy homeostasis [J]. Trends Mol Med , 2008 , 14 ( 12 ): 539 - 549 .
0
浏览量
15
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构